Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell MalignanciesNivesh Mittal, G. Christopher Wood|Pharmaceutics|2018Cited by 5
Design, Development, Characterization and Testing of CD22 Targeted Long Circulating Liposomal Drug Delivery Systems for B Cell MalignanciesNivesh Mittal|Unknown|2015Cited by 0